Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Daunorubicin × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Burkitt Lymphoma 6 Myelodysplastic Syndromes 5 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Myeloproliferative Disorders 2 Sarcoma, Myeloid 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Acute Myeloid Leukemia With KMT2A Rearrangement 1

Interventions

fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 liposomal doxorubicin 1 isatuximab 1 dabrafenib 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Thiotepa 1 Specimen Handling 1 Sirolimus 1 Prednisone 1 Nivolumab 1 Lenalidomide 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Genetic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡